Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle

Basic Research in Cardiology

Volumn 92, Issue 4, 1997, Pages 252-260

  Carr, C S ^a   Yellon, D M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Human atrium; Ischaemic preconditioning; K(ATP) channel openers; Pre operative nicorandil

Indexed keywords

ADENOSINE TRIPHOSPHATE; NICORANDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ARTICLE; HEART ATRIUM; HEART ATRIUM MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN TISSUE; PREOPERATIVE PERIOD; REOXYGENATION;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; ANGINA PECTORIS; BENZOPYRANS; CROMAKALIM; FEMALE; GUANIDINES; HEART ATRIA; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NIACINAMIDE; NICORANDIL; POTASSIUM CHANNELS; VASODILATOR AGENTS;

EID: 0030791703     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00788520     Document Type: Article

References (29)

1. Asimakis GK, Inners-McBride K, Medelin G, Conti VR (1992) Ischaemic preconditioning attenuates acidosis and postischaemic dysfunction in isolated rat heart. Am J Physiol 32: H887-H892
2. Auchampach J, Grover G, Gross G (1992) Blockade of ischaemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26: 1054-62
3. Carr C, Yellon D (1996) A highly selective ATP-dependent potassium channel opener mimics ischaemic preconditioning protection in isolated human atrium. Med Sci Res 24: 651-654
4. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, Merchant S, Chan C, Letac B (1992) Improved myocardial ischaemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 20: 578-86
5. Downey JM, Liu GS, Thornton JD (1993) Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 27: 3-8
6. Frampton J, Buckley M, Fitton A (1992) Nicorandil. A Review of its Pharmacology and Therapeutic Efficacy in Angina Pectoris. Drugs 44: 625-655
7. Frydman A, Chapelle P, Diekmann H, Bruno R, Thebault J, Bouthier J, Caplain H, Ungethuem W, Gaillard C, Le Liboux A (1989) Pharmacokinetics of nicorandil. Am J Cardiol 63: 25-33J
8. Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Research 70: 223-233
9. Grover G, D'Alonzo A, HessT, Sleph P, Darbenzio R (1995) Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 30: 731-738
10. Grover G, Dzwonczyk S, Parham C, Sleph P (1990) The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in dogs in the absence of haemodynamic changes. Cardiovasc Drugs Ther 4: 465-74
11. Hamilton T, Weston A (1989) Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 20: 1-9
12. Hecquet C, Mestre M, Cavero I (1994) Synergistic cardioprotective effect of a subthreshold concentration of aprikalim and a subthreshold ischaemic preconditioning stress. Circulation 90: I-48 (No 0246)
13. Heidbuchel H, Vereecke J, Carmeliet E (1990) Three different potassium channels in human atrium: contribution to the basal potassium conductance. Circ Research 66: 1277-1286
14. Hiraoka M, Fan Z (1989) Activation of ATP-sensitive outward potassium current by nicorandil (2-nicotinamidoethyl-nitrate) in isolated ventricular myocytes. J Pharmacol ExpTher 250: 278-285
15. Jenkins D, Pugsley W, Yellon D (1995) Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol 27: 1623-1632
16. Kida M, Yokota R, Tanaka M (1992) Effect of ischaemic preconditioning on energy metabolism during short sustained ischaemia and reperfusion in pig hearts. J Moll Cell Cardiol 24: II-S.5
17. Kloner R, Shook T, Przyklenk K, Davis V, Junio L, Matthews R, Burstein S, Gibson M, Poole K,Cannon C, McCabe C, Braunwald E (1995) Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 91: 37-47
18. ATP channel but not by its nitrate-like properties in dogs. Cardiovasc Res 32: 274-285
19. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124-1136
20. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischaemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischaemic episode. Circ Research 66: 913-931
21. Ovize M, Przyklenk K, Hale S, Kloner R (1992) Preconditioning does not attenuate myocardial stunning. Circulation 85: 2247-2254
22. Speechly-Dick ME, Grover GJ, Yellon DM (1995) Does ischaemic preconditioning in the human involve Protein Kinase C and the ATP-dependent K+ channel? Studies of contractile function following simulated ischaemia in an atrial in vitro model. Circ Research 77: 1030-1035
23. Suryapranata H, MacLeod D (1992) Nicorandil and cardiovascular performance in patients with coronary artery disease. J Cardiovasc Pharmacol 20 (suppl 3): S45-51
24. Tomai F, Crea F, Gaspardone A, Versaci F, Esposito C, Chiariello L, Gioffre P-A (1993) Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol 22: 1892-1896
25. Walker D, Walker J, Pugsley W, Pattison C, Yellon D (1995) Preconditioning in isolated superfused human muscle, J Mol Cell Cardiol 27: 1349-57
26. Warltier D, Auchampach J, Gross G (1993) Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation. J Cardiovasc Surg 8 (suppl): 279-83
27. Yao Z, Gross G (1994) Activation of ATP-sensitive potassium channels lowers threshold for ischaemic preconditioning in dogs. Am J Physiol 267: H1888-94
28. Yao Z, Gross G (1994) Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 89: 1769-75
29. Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. The Lancet 342: 276-277